Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Class 2 Device Recall AmoO Herbal Stimulator

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
  Class 2 Device Recall AmoO Herbal Stimulator see related information
Date Initiated by Firm February 03, 2014
Date Posted April 24, 2014
Recall Status1 Open3, Classified
Recall Number Z-1498-2014
Recall Event ID 67976
Product Classification Amo-O Herbal Stimulator - Product Code NA
Product Amo-O Herbal Stimulator, 2 fl. oz. Manufactured by Meta Labs, Alpharetta, GA 30076, UPC Code 80702-1

Product Usage:
The product is a nonprescription, topical gel that is used to enhance libido and stimulate orgasmic pleasure.
Code Information Lot 8-94034
Recalling Firm/
Manufacturer		 Altasource LLC dba Meta Labs LLC
1009 Mansell Rd Ste J
Roswell GA 30076-4806
For Additional Information Contact Sam Khayat
770-645-0602
Manufacturer Reason
for Recall		 Firm is not registered as a drug manufacturer.
FDA Determined
Cause 2		 No Marketing Application
Action Meta Labs notified customers of the Voluntary Recall Notification letter on February 4, 2014. The letter requested that the products be returned. For questions call 770-645-0602.
Quantity in Commerce 70
Distribution USA Nationwide in the states of AZ, AR, CA, CO, FL, GA, ID, IL,KY, LA, MI, NE, NV, NY, NC, OH, PA, TN, TX, UT, and VA.
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 The manufacturer has initiated the recall and not all products have been corrected or removed. This record will be updated as the status changes.
-
-